American College of Clinical Pharmacy
      Search      Cart
         

PSAP in JACCP - Part I: Case Series: Pancreatitis and Part II: Recorded Webcast: Vaping - 2024 September


Member Price:
$29.95
Nonmember Price:
$29.95

PSAP in JACCP features are developed from activities presented as part of the Pharmacotherapy Self-Assessment Program (PSAP).

Part I: Case Series: Pancreatitis
This feature was developed from a case series presented in PSAP 2023 Book 3 (Pulmonary and Gastrointestinal Diseases).
  • Case Series: Click here to access the case series.
Part II: Recorded Webcast: Vaping

This feature was developed from a recorded webcast presented in PSAP 2023 Book 3 (Pulmonary and Gastrointestinal Diseases).

  • Case Series: Click here to access the case series.
Release Date: September 08, 2024
BCPS Deadline: March 08, 2025
ACPE Deadline: September 08, 2027

Publication Year: 2024
Format: Online Test

Contents

Part I: Case Series: Pancreatitis

Part II: Recorded Webcast: Vaping

Part I: Case Series: Pancreatitis

Faculty

Abigail M. Yancey, Pharm.D., FCCP, BCPS

St Louis College of Pharmacy
St. Louis, Missouri

Reviewers

Patrick Finnegan, Pharm.D., B.S.Pharm, BCPS

Clinical Specialist
Transitions of Care Barnes-Jewish Hospital

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American College of Clinical Pharmacy is approved by BPS as a provider for the recertification of BCPS.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: Pharmacotherapy specialists and advanced level clinical pharmacists whose practice involves the direct care and management of patients with pulmonary and /or gastrointestinal diseases.

Contents

Part I: Case Series: Pancreatitis

Activity Number: 0217-0000-24-192-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based

Learning Objectives
  1. Evaluate patients for the etiology, pathophysiology, and risk factors associated with acute pancreatitis (AP) and chronic pancreatitis (CP).
  2. Assess the severity of AP and CP in the clinical presentation (i.e., patient history, symptoms, laboratory values, and imaging) of a patient with AP and CP.
  3. Develop an evidence-based, patient-specific plan for the treatment of AP and CP.

Part II: Recorded Webcast: Vaping

Activity Number: 0217-0000-24-193-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based

Learning Objectives
  1. Classify the different types of electronic nicotine delivery systems (ENDS) and the additives used.
  2. Account for regulations and laws associated with vaping products.
  3. Assess the likelihood of e-cigarette, or vaping, product use-associated lung injury (EVALI) given the clinical presentation (i.e., patient history, symptoms, laboratory values, and imaging) of a patient with a history of vape use.
  4. Develop a patient-specific treatment plan using available evidence for the treatment of EVALI and thrombotic complications.

Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.